Cochlear Ltd
(ASX:COH) has posted a 19% increase in net profit to $155.2 million for the year ended 30 June.
The hearing implant company also recorded 6% growth in revenue to almost $725 million, and earnings before interest and tax rose 20% to $220.5 million for the 2010 financial year.
A final dividend of $1.05 per share, 60% franked, has been declared by the company.
Cochlear says the dynamics of the implantable hearing device industry remain positive and that its latest generation implant and sound processor, the Nucleus 5, will continue to underpin growth in the 2011 financial year.
Cochlear reported a profit of $130.5 million for the year to 30 June 2009.
